The 'receptor agonist' label that's often added refers to the way these drugs connect to and activate cell docking points called GLP-1 receptors, just like the real hormone
These areas like under the chin, the thighs, or the abdomen often resist even the strictest diets and rigorous workouts
In ob/ob obese mice, a low iron diet or iron chelation therapy protected against -cell failure and insulin resistance and lowered triglycerides, but these effects were not replicated in healthy weight mice [38]
El gran problema de estos frmacos es que no diferencian entre grasa y msculo, lo que aumenta el riesgo de sarcopenia, es decir, fragilidad, prdida de masa muscular y peor calidad de vida, sobre todo en pacientes de edad avanzada (25)
Many patients and providers arent aware that GLP-1 medications may seem new and novel, but preclinical studies began in the early 1980s